
    
      This is a prospective, multicenter, post-market clinical follow-up, non-randomized registry
      of the TREO Stent-Graft. Subjects diagnosed with infrarenal aortic aneurysms and treated with
      the TREO Stent-Graft or TREO aorto-uni-iliac (AUI) device can be included into the registry.
      Pre-procedure baseline data will be gathered as well as post-procedure assessments prior to
      hospital discharge and one to three months and 1, 2, 3, 4, and 5-year post-implantation.

      The objective of the registry is to assess the clinical results and health economics of the
      TREO device in a real-world population of patients with infrarenal abdominal aortic aneurysms
      (AAA).
    
  